FDA PMA FDA Class 3 Approved 🇺🇸 United States

Coronary Drug-Eluting Stent

PMA: P030025 · Supplement: S002 · Decision May 5, 2004
Classifications
1
FEI Numbers
32
Registration Numbers
32

Basic Information

Device Name
Coronary Drug-Eluting Stent
Trade Name
TAXUS EXPRESS2 MONORAIL AND OVER-THE-WIRE CORONARY STENT SYSTEMS
PMA Number
P030025
Supplement Number
S002
Device Class
FDA Class 3
Product Code
NIQ
Generic Name
Coronary drug-eluting stent
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
May 5, 2004
Date Received
April 5, 2004
Supplement Type
Special (Immediate Track)
Expedited Review
N

Advisory Committee Statement

APPROVAL TO IMPLEMENT THE FOLLOWING: 1) THE ADDITION OF AN ADDITIONAL IN-PROCESS INSPECTION, 2) MODIFICATION OF A CURRENT IN-PROCESS INSPECTION, AND 3) MODIFICATION OF A MANUFACTURING PROCESS TO ADDRESS COMPLAINTS RELATED TO FAILURE OF THE DELIVERY SYSTEM BALLOON TO PROPERLY DEFLATE FOLLOWING STENT DEPLOYMENT.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIQ Coronary Drug-Eluting Stent